Brief description of case studies Sample Clauses

Brief description of case studies. The report is structured around selected case studies, manly involving the analysis of existing datasets collected within Wiser. The case studies come from different European lake types in the Northern, Central, Alpine and Mediterranean regions and offer different angles and approaches to quantify the spatial and temporal variations of invertebrates. Xxxxx Xxxxxxx and coworkers focus on the variability of different invertebrate metrics looking at a very long time series of data coming from the shallow lake Naardermeer. Time-for-space analysis is used to disentagle the unexplained variation caused by replicate samples, sample processing, natural temporal variation and stochastic events in the data series of 23 years of macroinvertebrate data and abiotic variables. Xxxxxxxxx Xxxxxxx and Xxxxxx Xxxxxxxx use the variance partitioning approach in order to quantify the combined impact of eutophication and morphological pressures on the invertebrate assemblages inhabiting different lake zones of 57 Alpine lakes. This method allows to disentangle the problem of interactions among different groups of explaining factors including variables connected to the pure spatial pattern and to lake morphology and geology By including those sets of variables in the variance partitioning analysis the authors could isolate the pure effects of eutrophication and morphological pressures from the effects due to interactions with the other tested variables. Despite the great importance of those water bodies in areas of water scarcity, data from Mediterranean natural lakes are particularly scarce. For this reason, Xxxxxxxx Xxxxxxxx and coworkers look at the response to eutrophication of qualitative metrics (e.g. those based on presence – absence data) in different zones of lakes belonging to the volcanic district of Italy. A list of several taxa is proposed as tolerant and sensitive to euthrophication stressors that might be used in the development of the complete WFD compliant classification system. Xxxxxx XxXxxx and Xxxxxxx Xxxxxx apply a multivariate method in order to partition the variance of littoral invertebrates between riparian related habitat variables, littoral substrate variables and trophic status of Swedish lakes. They also look at the impact of large scale land use patterns, investigating whether invertebrate communities in impaired and natural lakes differ in their response to local habitat and nutrient descriptors, and how the different environmental descriptors affe...
AutoNDA by SimpleDocs

Related to Brief description of case studies

  • Brief Description Identification of the device: mirror, camera/monitor, other device 2/ Device for indirect vision of Class I, II, III, IV, V, VI, S 2/ Δ Symbol 2m as defined in paragraph 6.1.3.1.1. of this Regulation: yes/no 2/ Annex 3

  • Project Description In two or three brief sentences, provide a concise description of your exhibition. Include the subject matter, type of objects to be included (paintings, sculpture, manuscripts, etc.), those responsible for organizing the exhibition, and catalogue author(s).

  • Task Description This task includes activities associated with permit-required monitoring conducted in accordance with the conditions specified by state or federal regulatory agencies. All monitoring tasks must be located within or adjacent to the Project area and follow the Department’s Regional Coastal Monitoring Program and FWC's marine turtle and shorebird monitoring programs. Guidance for monitoring of nearshore resources is available in the Department's Standard Operation Procedures For Nearshore Hardbottom Monitoring Of Beach Nourishment Projects. The Local Sponsor must submit work products directly to the appropriate state or federal regulatory agencies in accordance with permit conditions to be eligible for reimbursement under this task, unless otherwise directed.

  • General Project Description 2. Substation location.

  • Topic Description Licensee Responsibilities Licensee must:  Take appropriate steps to ensure the security, integrity, and confidentiality of Confidential Information and must comply with all relevant applicable laws and regulations, including laws protecting borrower privacy.  Not disclose Confidential Information to third parties, without Xxxxxx Mae’s prior written approval, except on a need‐to‐know basis to Licensee’s partners, Topic Description affiliates, officers, employees, directors, contractors, counsels, agents or representatives, provided they are subject to confidentiality obligations at least as stringent as those set forth in this Section A3.  Not use Confidential Information in any way that could be viewed as a conflict of interest, a breach of confidentiality or privacy, or the gaining of an unfair advantage from the relationship with Xxxxxx Xxx.  Implement commercially reasonable measures meeting or exceeding industry standards to ensure the security, integrity, and confidentiality of Confidential Information, including using industry‐standard encryption for data in transit and virus checking programs designed to prevent the transmission and receipt of viruses and other malicious code, implementing appropriate disaster recovery and back‐up procedures, implementing appropriate procedures to prevent disclosure of data and other materials to a party other than the intended recipient, and employing methods for securely disposing or destroying such information.  These measures must meet, at least, the same level of protection that the Receiving Party seeks for its own information of a similar nature.  Licensee must collaborate with Xxxxxx Mae in assessing the sufficiency of these measures and Licensee’s information security program, upon reasonable request.  Instruct its Related Parties who may receive Confidential Information about the requirements of this Section A3, and the processes and procedures necessary to comply with them.  Comply with all reasonable security policies and procedures required by Xxxxxx Xxx related to the access and use of Xxxxxx Mae’s systems or any Licensed Materials.  Not transmit to Xxxxxx Mae’s systems any materials that contain bugs, viruses, worms or other functions, routines, devices or instructions which may create any unauthorized access or damage to, or interruption in the functioning of, the Licensed Application or Xxxxxx Mae’s systems. Restrictive Legends  Licensee must abide by and reproduce and include any restrictive legend or proprietary rights notice that appears in or on any Confidential Information of Xxxxxx Xxx or any Third‐Party Licensor (or other third‐party owner) that it is authorized to reproduce.  Licensee also agrees that it will not remove, alter, cover or distort any trademark, trade name, copyright or other proprietary rights notices, legends, symbols or labels appearing on or in any Confidential Information of Xxxxxx Mae or any Third‐Party Licensor (or other third‐party owner). Required Actions in Case of Data Breach  Licensee must address any Data Breach with prompt and effective corrective action, including cooperation with Xxxxxx Xxx in the investigation and remediation of such Data Breach, as well as prompt disclosure and notification where legally required; and  Licensee must promptly notify Xxxxxx Mae of any Data Breach in writing ‐‐ at xxxxxxx_xxxxxxxxxxxx@xxxxxxxxx.xxx ‐‐ and must take all steps reasonably requested by Xxxxxx Xxx to mitigate the consequences of such Data Breach.

  • Work Description T-804 Opening Roads - Removal of closure devices, cleaning ditches, removing berms, and blading the traveled-way T-811 Closing Roads - Entrance treatment for 150' cross-rip; debris block (slash, earth, berm, rocks, etc.) + seed + water bar T-811 Closing Roads - Water bar frequency per BMPs for remainder of road T-811 Closing Roads - Engineering Rep. or Construction Inspector must be notified prior to performing closeout NFSR Road No. Lane Width & Maintenance Level Mile Marker Begin End 76L Single Lane / Level 2 76 0.00 Ending 0.48

  • Site Description 2.5.1 If reasonably requested by the A/E as necessary for the Project, the Owner shall furnish a legal description and a certified land survey of the Site, giving, as applicable, grades and lines of streets, alleys, pavements and adjoining property; rights-of-way, restrictions, easements, encroachments, zoning, deed restrictions, boundaries and contours of the Site; locations, dimensions, and complete data pertaining to existing buildings, other improvements, and trees; and full information concerning available service and utility lines, both public and private, above and below grade, including inverts and depths.

  • Product Description The lead products covered by this Settlement Agreement is limited to following Amazon Identification Number (ASIN) B0BBMRLNV9, with the description, "Lesnow 63-37 Tin Lead Rosin Core Solder Wire for Electrical Soldering 0.8mm Soldering Wire Electronics Solder Content Solder Flux 1.8% (0.8mm, 50g)," which was offered for sale by the Settling Entity on xxxxxx.xxx, hereinafter the “Product” or “Products.”

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Phase 2 Phase 2 is expected to consist of Member Nodes and a select number of Nodes operated by non-Members. The non-Member Nodes will be required to comply with Node hosting terms as set forth by the Council, which may be amended from time to time (the “General Node Terms”).

Time is Money Join Law Insider Premium to draft better contracts faster.